Patients with hereditary hemochromatosis reach safe range of transferrin saturation sooner with erythrocytaphereses than with phlebotomies

Patients with hereditary hemochromatosis reach safe range of transferrin saturation sooner with erythrocytaphereses than with phlebotomies

Introduction For the maintenance treatment of patients with hereditary hemochromatosis (HH), it is advised to keep the transferrin saturation (TSAT)

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical apheresis 2022-02, Vol.37 (1), p.100-105
Hauptverfasser: Rombout‐Sestrienkova, Eva, Brandts, Lloyd, Koek, Ger H., Deursen, Cees Th. B. M
Format: Artikel
Sprache:eng
Schlagworte:
Apheresis
Blood Component Removal
Blood diseases
Female
Hemochromatosis - blood
Hemochromatosis - therapy
hereditary hemochromatosis
Humans
Male
Phlebotomy
therapeutic erythrocytapheresis
Time Factors
Transferrin - analysis
transferrin saturation
Treatment Outcome
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Introduction For the maintenance treatment of patients with hereditary hemochromatosis (HH), it is advised to keep the transferrin saturation (TSAT)
ISSN:0733-2459
1098-1101
DOI:10.1002/jca.21956